Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2010-10-13 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BLAGNAC (31700), Haute-Garonne
SELARL PHARMACIE DU RITOURET : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU RITOURET is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BLAGNAC (31700),
this company of category PME
shows in 2023 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU RITOURET (SIREN 528371677)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 398 417 €
1 459 745 €
1 610 658 €
1 487 396 €
1 214 507 €
1 156 938 €
1 168 631 €
1 202 875 €
Net income
31 263 €
32 764 €
45 057 €
160 721 €
73 022 €
53 123 €
53 286 €
56 979 €
57 886 €
EBITDA
N/C
44 978 €
45 782 €
221 450 €
113 294 €
88 502 €
88 205 €
92 669 €
101 669 €
Net margin
N/C
2.3%
3.1%
10.0%
4.9%
4.4%
4.6%
4.9%
4.8%
Revenue and income statement
In 2024, SELARL PHARMACIE DU RITOURET generates positive net income of 31 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 58 k€ -> 31 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
31 263 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.942%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
79.784%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU RITOURET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
126.178
105.546
94.187
68.315
49.094
26.853
12.113
13.396
6.942
Financial autonomy
35.19
39.382
44.886
50.618
57.006
66.168
71.636
73.12
79.784
Repayment capacity
6.359
6.415
6.331
5.028
2.995
1.266
3.001
3.044
None
Cash flow / Revenue
6.223%
6.109%
5.747%
5.547%
5.858%
10.431%
2.315%
2.374%
None%
Sector positioning
Debt ratio
6.942024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of SELARL PHARMACIE DU RITOURET (6.94) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
79.78%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+7 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DU RITOURET (79.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
3.04 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of SELARL PHARMACIE DU RITOURET (3.04) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 116.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
116.659
Liquidity indicators evolution SELARL PHARMACIE DU RITOURET
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
51.662
46.567
51.811
46.158
52.672
84.89
57.001
69.668
116.659
Interest coverage
11.528
15.018
11.695
9.065
5.571
1.434
6.734
10.936
None
Sector positioning
Liquidity ratio
116.662024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch+12 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DU RITOURET (116.66) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
10.94x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of SELARL PHARMACIE DU RITOURET (10.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU RITOURET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
58 700 €
36 485 €
53 994 €
43 710 €
49 932 €
32 503 €
32 290 €
86 296 €
0 €
Inventory turnover (days)
31
24
22
22
18
17
18
27
0
Customer payment term (days)
3
4
6
3
6
6
2
7
0
Supplier payment term (days)
65
61
40
45
33
35
45
46
0
Positioning of SELARL PHARMACIE DU RITOURET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DU RITOURET is estimated at
436 454 €
(range 303 940€ - 652 961€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
303k€436k€652k€
436 454 €Range: 303 940€ - 652 961€
NAF 5 année 2024
Valuation method used
Net Income Multiple
31 263 €
×
14.0x
=436 455 €
Range: 303 940€ - 652 961€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU RITOURET with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU RITOURET
What is the revenue of SELARL PHARMACIE DU RITOURET ?
The revenue of SELARL PHARMACIE DU RITOURET in 2023 is 1.4 M€.
Is SELARL PHARMACIE DU RITOURET profitable?
Yes, SELARL PHARMACIE DU RITOURET generated a net profit of 31 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DU RITOURET ?
The headquarters of SELARL PHARMACIE DU RITOURET is located in BLAGNAC (31700), in the department Haute-Garonne.
Where to find the tax return of SELARL PHARMACIE DU RITOURET ?
The tax return of SELARL PHARMACIE DU RITOURET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU RITOURET operate?
SELARL PHARMACIE DU RITOURET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart